SCHEMBL3966697

SCHEMBL3966697

CCCCCCc1ccc(Oc2ccc(CN(Cc3ccc(F)cc3F)c3cccc([N+](=O)[O-])c3C)cc2)cc1O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 14/20 0.50
PGR P06401 3/20 0.47
NR3C2 P08235 1/20 0.45
AR P10275 1/20 0.45
TAS2R14 Q9NYV8 1/20 0.34
HTR2A P28223 1/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX5 P09917 1/20 0.34
MAPT P10636 1/20 0.34
TYR P14679 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970484 0.90 NR3C1 (0.55) NR3C1PGRNR3C2ARTAS2R14
SCHEMBL3969499 0.89 NR3C1 (0.59) NR3C1PGRNR3C2ARMEN1
SCHEMBL3969492 0.89 NR3C1 (0.59) NR3C1PGRNR3C2ARMEN1
SCHEMBL3963416 0.88 NR3C1 (0.57) NR3C1PGRNR3C2ARTAS2R14
SCHEMBL3960392 0.87 NR3C1 (0.54) NR3C1PGRNR3C2ARTAS2R14
SCHEMBL3970080 0.87 NR3C1 (0.54) NR3C1PGRNR3C2ARTAS2R14
SCHEMBL3966997 0.87 NR3C1 (0.46) NR3C1PGRNR3C2ARHTR2A
SCHEMBL3967760 0.86 NR3C1 (0.54) NR3C1PGRNR3C2ARTAS2R14
SCHEMBL3967049 0.84 NR3C1 (0.53) NR3C1PGRNR3C2ARTAS2R14
SCHEMBL3972710 0.84 NR3C1 (0.58) NR3C1PGRNR3C2ARTAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363876-B1 GLUCOCORTICOID RECEPTOR MODULATORS KAROBIO AB (SE) 2009-07-29 EP disclosed
EP-1363876-A1 GLUCOCORTICOID RECEPTOR MODULATORS Abbott Laboratories (US) 2003-11-26 EP disclosed
US-6583180-B2 Antidiabetic agents ABBOTT LABORATORIES 2003-06-24 US disclosed
US-20020156311-A1 Glucocorticoid receptor modulators KARO BIO AB (SE) 2002-10-24 US disclosed
WO-2002064550-A1 GLUCOCORTICOID RECEPTOR MODULATORS ABBOTT LABORATORIES (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156311-A1 Glucocorticoid receptor modulators NR3C1, NR5A1, NR3C2 NR3C1 1/4885PGR 249/4885NR3C2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.